(Q46525724)

22 December 2017

title

The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients (English)

1 reference

22 December 2017

0 references

Day DG

1

1 reference

22 December 2017

Sharpe ED

2

1 reference

22 December 2017

Atkinson MJ

3

1 reference

22 December 2017

Stewart JA

4

1 reference

22 December 2017

Stewart WC

5

1 reference

22 December 2017

publication date

1 May 2006

1 reference

22 December 2017

published in

Eye

1 reference

22 December 2017

volume

20

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

583-590

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.eye.6701932

exact match

0 references

cites work

Measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

Psychometric considerations in evaluating health-related quality of life measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

Development of the 25-item National Eye Institute Visual Function Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

Quality of life in glaucoma and its relationship with visual function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

A new measure of patient satisfaction with ocular hypotensive medications: the Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

Glaucoma patients not compliant with their drug therapy: clinical and behavioural aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

Methods for measuring patient satisfaction with specific medical encounters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

7 January 2021

Contribution of multiple glaucoma medications to visual function and quality of life in patients with glaucoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

7 January 2021

The Glaucoma Symptom Scale. A brief index of glaucoma-specific symptoms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

7 January 2021

Dorzolamide versus pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

7 January 2021

Compliance with topical timolol treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

7 January 2021

Compliance with topical pilocarpine treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

7 January 2021

Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

7 January 2021

Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701932

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6701932

1 reference

22 December 2017

1 reference

22 December 2017